Stock Chart

BHC

$6.37 -1.85%
Score: 48.2 HOLD
LEAPs: SELL $5
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $5
Premium: $1.12
Expiry: Jan 15, 2027
Target: $5
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.50x (vs SPY: 1.0x | vs QQQ: 0.9x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 23, 2026
Symmetrical Triangle Bullish scenario quality 61/100
Measured-move target $6.95 (+9.1%) · apex ~24 bars ahead
Historically breaks up 54% overall; 71% up when formed in a downtrend (n=131)
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and target are drawn on the chart below.
Technical Chart
OVERLAYS
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
SETTINGS
Active (2)
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About BHC - Bausch Health Companies Inc

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Key Statistics

Market Cap $2B

More BHC Analysis

Buy or Sell Analysis Price Prediction AI Analysis Fair Price Options Advisor Trendline Analysis

This BHC stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track BHC's price movements with trendlines, gamma walls, and key support/resistance levels.